| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |